Biotech M&A boom sees Sanofi snapping up Ablynx

ReutersNewsPublished: January 29, 2018
Published: January 29, 2018

French drugmaker Sanofi agrees to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ. Amy Pollock reports.

Be the first to suggest a tag

    Comments

    0 comments